{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:53:15Z","timestamp":1785538395540,"version":"3.56.0"},"reference-count":57,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":142,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.csbj.2023.05.023","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T13:46:36Z","timestamp":1685022396000},"page":"3159-3172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90\/Cdc37 interaction for treating hepatocellular carcinoma"],"prefix":"10.34133","volume":"21","author":[{"given":"Surya","family":"Sukumaran","sequence":"first","affiliation":[{"name":"The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Henrietta Szold St. 8, Safed 1311502, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdian","family":"Tan","sequence":"additional","affiliation":[{"name":"Asian Liver Center, Department of Surgery, Stanford University School of Medicine, 1201 Welch Road, Palo Alto, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulamit Fluss","family":"Ben-Uliel","sequence":"additional","affiliation":[{"name":"The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Henrietta Szold St. 8, Safed 1311502, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Asian Liver Center, Department of Surgery, Stanford University School of Medicine, 1201 Welch Road, Palo Alto, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"De Zotti","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Padova, Via Marzolo 1, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Sze","family":"Chua","sequence":"additional","affiliation":[{"name":"Asian Liver Center, Department of Surgery, Stanford University School of Medicine, 1201 Welch Road, Palo Alto, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"So","sequence":"additional","affiliation":[{"name":"Asian Liver Center, Department of Surgery, Stanford University School of Medicine, 1201 Welch Road, Palo Alto, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Qvit","sequence":"additional","affiliation":[{"name":"The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Henrietta Szold St. 8, Safed 1311502, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3"},{"key":"e_1_3_5_4_2","first-page":"506","article-title":"Update on the diagnosis and treatment of hepatocellular carcinoma","volume":"16","author":"Ferrante N.D.","year":"2020","unstructured":"Ferrante N.D., Pillai A. and Singal A.G.: Update on the diagnosis and treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) 2020; 16: 506.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva A.","year":"2019","unstructured":"Villanueva A.: Hepatocellular carcinoma. New Engl J Med 2019; 380: 1450.","journal-title":"New Engl J Med"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability","volume":"19","author":"McGlynn K.A.","year":"2015","unstructured":"McGlynn K.A., Petrick J.L. and London W.T.: Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 2015; 19: 223.","journal-title":"Clin Liver Dis"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3748\/wjg.v20.i2.333","article-title":"Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives","volume":"20","author":"Ma L.","year":"2014","unstructured":"Ma L. et al: Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol 2014; 20: 333.","journal-title":"World J Gastroenterol"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng A.L.","year":"2022","unstructured":"Cheng A.L. et al: Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol 2022; 76: 862.","journal-title":"J Hepatol"},{"key":"e_1_3_5_9_2","first-page":"12","article-title":"Molecular signaling pathways and therapeutic targets in hepatocellular carcinoma","author":"Dimri M.","year":"2020","unstructured":"Dimri M. and Satyanarayana A.: Molecular signaling pathways and therapeutic targets in hepatocellular carcinoma. Cancers 2020; : 12.","journal-title":"Cancers"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.18632\/oncotarget.2171","article-title":"Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts","volume":"5","author":"Wei W.","year":"2014","unstructured":"Wei W. et al: Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts. Oncotarget 2014; 5: 5819.","journal-title":"Oncotarget"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.21807"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80928-9"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10317"},{"key":"e_1_3_5_14_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-319-11731-7_5","article-title":"Cdc37 as a co-chaperone to Hsp90","volume":"78","author":"Calderwood S.K.","year":"2015","unstructured":"Calderwood S.K.: Cdc37 as a co-chaperone to Hsp90. Subcell Biochem 2015; 78: 103.","journal-title":"Subcell Biochem"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-031-14740-1_5","article-title":"Cdc37 as a Co-chaperone to Hsp90","volume":"101","author":"Prince T.L.","year":"2023","unstructured":"Prince T.L. et al: Cdc37 as a Co-chaperone to Hsp90. Subcell Biochem 2023; 101: 141.","journal-title":"Subcell Biochem"},{"key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1002\/jcp.29776","article-title":"The role of HSP90 molecular chaperones in hepatocellular carcinoma","volume":"235","author":"Nouri-Vaskeh M.","year":"2020","unstructured":"Nouri-Vaskeh M. et al: The role of HSP90 molecular chaperones in hepatocellular carcinoma. J Cell Physiol 2020; 235: 9110.","journal-title":"J Cell Physiol"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.11.015"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1000"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.11.003"},{"key":"e_1_3_5_20_2","volume-title":"Peptides and Peptidomimetics as Foundations for Drug Discovery, in Encyclopedia of Molecular Pharmacology","author":"Qvit N.","year":"2021","unstructured":"Qvit N.: Peptides and Peptidomimetics as Foundations for Drug Discovery, in Encyclopedia of Molecular Pharmacology. Edited by S. Offermanns and W. Rosenthal. : Springer 2021."},{"key":"e_1_3_5_21_2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cbpa.2008.03.009","article-title":"Peptidomimetics, a synthetic tool of drug discovery","volume":"12","author":"Vagner J.","year":"2008","unstructured":"Vagner J., Qu H. and Hruby V.J.: Peptidomimetics, a synthetic tool of drug discovery. Curr Opin Chem Biol 2008; 12: 292.","journal-title":"Curr Opin Chem Biol"},{"key":"e_1_3_5_22_2","doi-asserted-by":"crossref","DOI":"10.1039\/D0CS00102C","article-title":"Peptidomimetic toolbox for drug discovery","author":"Lenci E.","year":"2020","unstructured":"Lenci E. and Trabocchi A.: Peptidomimetic toolbox for drug discovery. Chem Soc Rev 2020; .","journal-title":"Chem Soc Rev"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/1568026618666180518094322","article-title":"Conversion of protein active regions into peptidomimetic therapeutic leads using backbone cyclization and cycloscan\u2013how to do it yourself!","volume":"18","author":"Rubin S.J.","year":"2018","unstructured":"Rubin S.J. et al: Conversion of protein active regions into peptidomimetic therapeutic leads using backbone cyclization and cycloscan\u2013how to do it yourself!. Curr Top Med Chem 2018; 18: 556.","journal-title":"Curr Top Med Chem"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/1568026618666180518092333","article-title":"Backbone-cyclized peptides: a critical review","volume":"18","author":"Rubin S.J.S.","year":"2018","unstructured":"Rubin S.J.S. and Qvit N.: Backbone-cyclized peptides: a critical review. Curr Top Med Chem 2018; 18: 526.","journal-title":"Curr Top Med Chem"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2019.1676720"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2020.00697","article-title":"Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application","volume":"11","author":"Xie J.","year":"2020","unstructured":"Xie J. et al: Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application. Front Pharmacol 2020; 11: 697.","journal-title":"Front Pharmacol"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225546"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90263-2"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky357"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1093\/bioinformatics\/btac486","article-title":"Docking cyclic peptides formed by a disulfide bond through a hierarchical strategy","volume":"38","author":"Tao H.","year":"2022","unstructured":"Tao H. et al: Docking cyclic peptides formed by a disulfide bond through a hierarchical strategy. Bioinformatics 2022; 38: 4109.","journal-title":"Bioinformatics"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2"},{"key":"e_1_3_5_32_2","first-page":"15","article-title":"CFSSP: Chou and Fasman secondary structure prediction server","volume":"1","author":"Kumar T.A.","year":"2013","unstructured":"Kumar T.A.: CFSSP: Chou and Fasman secondary structure prediction server. Wide Spectrum 2013; 1: 15.","journal-title":"Wide Spectrum"},{"key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Solid phase peptide synthesis I. The synthesis of a tetrapeptide","volume":"85","author":"Merrifield R.B.","year":"1963","unstructured":"Merrifield R.B.: Solid phase peptide synthesis I. The synthesis of a tetrapeptide. J Am Chem Soc 1963; 85: 2149.","journal-title":"J Am Chem Soc"},{"key":"e_1_3_5_34_2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/bip.360310619","article-title":"Backbone cyclization: a new method for conferring conformational constraint on peptides","volume":"31","author":"Gilon C.","year":"1991","unstructured":"Gilon C. et al: Backbone cyclization: a new method for conferring conformational constraint on peptides. Biopolym Orig Res\u00a0Biomol 1991; 31: 745.","journal-title":"Biopolym Orig Res\u00a0Biomol"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1399-3011.1995.tb01065.x","article-title":"Preparation of the very acid-sensitive Fmoc-Lys(Mtt)-OH. Application in the synthesis of side-chain to side-chain cyclic peptides and oligolysine cores suitable for the solid-phase assembly of MAPs and TASPs","volume":"45","author":"Aletras A.","year":"1995","unstructured":"Aletras A. et al: Preparation of the very acid-sensitive Fmoc-Lys(Mtt)-OH. Application in the synthesis of side-chain to side-chain cyclic peptides and oligolysine cores suitable for the solid-phase assembly of MAPs and TASPs. Int J Pept Protein Res 1995; 45: 488.","journal-title":"Int J Pept Protein Res"},{"key":"e_1_3_5_36_2","article-title":"Exploring biomolecular interaction between the molecular chaperone hsp90 and its client protein kinase cdc37 using field-effect biosensing technology","volume":"181","author":"Lerner Y.","year":"2022","unstructured":"Lerner Y. et al: Exploring biomolecular interaction between the molecular chaperone hsp90 and its client protein kinase cdc37 using field-effect biosensing technology. JoVE 2022; 181: e63495.","journal-title":"JoVE"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2016.10.028"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2016.12.009"},{"key":"e_1_3_5_39_2","unstructured":"Schr\u00f6dinger L. and W. DeLano PyMOL Available at: \u3008http:\/\/www.pymol.org\/pymol\u3009. 2020."},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798322002261"},{"key":"e_1_3_5_41_2","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.jcim.0c00058","article-title":"Improving protein-peptide docking results via pose-clustering and rescoring with a combined knowledge-based and MM-GBSA scoring function","volume":"60","author":"Tao H.","year":"2020","unstructured":"Tao H., Zhang Y. and Huang S.Y.: Improving protein-peptide docking results via pose-clustering and rescoring with a combined knowledge-based and MM-GBSA scoring function. J Chem Inf Model 2020; 60: 2377.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_5_42_2","first-page":"14","article-title":"Peptide inhibitors of protein-protein interactions","volume":"28","author":"Mochly-Rosen D.","year":"2010","unstructured":"Mochly-Rosen D. and Qvit N.: Peptide inhibitors of protein-protein interactions. Chim Oggi\/Chem Today 2010; 28: 14.","journal-title":"Chim Oggi\/Chem Today"},{"key":"e_1_3_5_43_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevEukaryotGeneExpr.2016016525","article-title":"Cyclic peptides for protein-protein interaction targets: applications to human disease","volume":"26","author":"Rubin S.","year":"2016","unstructured":"Rubin S. and Qvit N.: Cyclic peptides for protein-protein interaction targets: applications to human disease. Crit Rev Eukaryot Gene Expr 2016; 26: 199.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"e_1_3_5_44_2","unstructured":"Frankel A. et al. TAT-derived transport polypeptide conjugates. 1998."},{"key":"e_1_3_5_45_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-62703-673-3_17","volume-title":"Circular Dichroism of Peptides, in Therapeutic Peptides: Methods and Protocols","author":"Bakshi K.","year":"2014","unstructured":"Bakshi K. et al: Circular Dichroism of Peptides, in Therapeutic Peptides: Methods and Protocols. Edited by A.E. Nixon. Totowa, NJ: Humana Press 2014: 247."},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/bip.360310511"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/liv.12651","article-title":"Suppressing the CDC 37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth","volume":"35","author":"Wang Z.","year":"2015","unstructured":"Wang Z. et al: Suppressing the CDC 37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth. Liver Int 2015; 35: 1403.","journal-title":"Liver Int"},{"key":"e_1_3_5_48_2","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ijc.31963","article-title":"Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma","volume":"144","author":"Augello G.","year":"2019","unstructured":"Augello G. et al: Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma. Int J Cancer 2019; 144: 2613.","journal-title":"Int J Cancer"},{"key":"e_1_3_5_49_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4161\/cbt.5.6.2907","article-title":"The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis","volume":"5","author":"Nyagol J.","year":"2006","unstructured":"Nyagol J. et al: The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther 2006; 5: 684.","journal-title":"Cancer Biol Ther"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/157016207781023974","article-title":"Oncogenic properties of HIV-Tat in colorectal cancer cells","volume":"5","author":"Huynh D.","year":"2007","unstructured":"Huynh D. et al: Oncogenic properties of HIV-Tat in colorectal cancer cells. Curr HIV Res 2007; 5: 403.","journal-title":"Curr HIV Res"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64156-9"},{"key":"e_1_3_5_52_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2180-5-20","article-title":"Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes","volume":"5","author":"Bettaccini A.A.","year":"2005","unstructured":"Bettaccini A.A. et al: Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes. BMC Microbiol 2005; 5: 20.","journal-title":"BMC Microbiol"},{"key":"e_1_3_5_53_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","article-title":"Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties","volume":"31","author":"Wilkening S.","year":"2003","unstructured":"Wilkening S., Stahl F. and Bader A.: Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 2003; 31: 1035.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104867"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-150"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2018.02.021"},{"key":"e_1_3_5_57_2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3892\/ol.2017.5557","article-title":"Targeting the Ras\/Raf\/MEK\/ERK pathway in hepatocellular carcinoma","volume":"13","author":"Yang S.","year":"2017","unstructured":"Yang S. and Liu G.: Targeting the Ras\/Raf\/MEK\/ERK pathway in hepatocellular carcinoma. Oncol Lett 2017; 13: 1041.","journal-title":"Oncol Lett"},{"key":"e_1_3_5_58_2","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.1074\/jbc.M200102200","article-title":"Requirement for a hsp90 chaperone-dependent MEK1\/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes","volume":"277","author":"Piatelli M.J.","year":"2002","unstructured":"Piatelli M.J., Doughty C. and Chiles T.C.: Requirement for a hsp90 chaperone-dependent MEK1\/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. J Biol Chem 2002; 277: 12144.","journal-title":"J Biol Chem"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037023002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037023002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2023.05.023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:09:09Z","timestamp":1778015349000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2023.05.023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":57,"alternative-id":["10.1016\/j.csbj.2023.05.023"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2023.05.023","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90\/Cdc37 interaction for treating hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2023.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}